Allstate (NYSE:ALL) Insider Suren Gupta Sells 400 Shares

The Allstate Corporation (NYSE:ALL) insider Suren Gupta sold 400 shares of the stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $215.22, for a total transaction of $86,088.00. Following the sale, the insider owned 100,646 shares in the company, valued at approximately $21,661,032.12. This trade represents a 0.40% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Suren Gupta also recently made the following trade(s):

• On Friday, November 14th, Suren Gupta sold 1,400 shares of Allstate stock. The shares were sold at an average price of $215.02, for a total value of $301,028.00.

Allstate Stock Performance

NYSE:ALL traded up $0.94 during midday trading on Tuesday, reaching $210.15. 1,492,677 shares of the company traded hands, compared to its average volume of 1,632,438. The firm has a market capitalization of $54.99 billion, a price-to-earnings ratio of 9.88, a price-to-earnings-growth ratio of 0.69 and a beta of 0.35. The company has a fifty day moving average price of $202.52 and a 200 day moving average price of $201.77. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43. The Allstate Corporation has a twelve month low of $176.00 and a twelve month high of $215.70.

Allstate (NYSE:ALL) last issued its earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share for the quarter, topping the consensus estimate of $5.48 by $5.69. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The firm had revenue of $17.26 billion for the quarter, compared to analyst estimates of $16.59 billion. During the same period last year, the company earned $3.91 earnings per share. The firm’s revenue for the quarter was up 3.8% on a year-over-year basis. On average, analysts expect that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Allstate

A number of institutional investors have recently added to or reduced their stakes in ALL. Brighton Jones LLC increased its position in shares of Allstate by 60.2% during the 4th quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider’s stock valued at $1,253,000 after purchasing an additional 2,443 shares during the period. Revolve Wealth Partners LLC bought a new position in Allstate during the fourth quarter valued at about $231,000. Kingsview Wealth Management LLC boosted its stake in Allstate by 33.3% during the first quarter. Kingsview Wealth Management LLC now owns 5,837 shares of the insurance provider’s stock valued at $1,209,000 after buying an additional 1,459 shares in the last quarter. Private Advisor Group LLC grew its holdings in Allstate by 0.9% during the first quarter. Private Advisor Group LLC now owns 18,007 shares of the insurance provider’s stock worth $3,729,000 after acquiring an additional 167 shares during the period. Finally, Kestra Private Wealth Services LLC raised its position in Allstate by 34.0% in the first quarter. Kestra Private Wealth Services LLC now owns 21,036 shares of the insurance provider’s stock worth $4,356,000 after acquiring an additional 5,340 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have commented on ALL. Evercore ISI set a $233.00 target price on shares of Allstate and gave the stock an “in-line” rating in a research report on Wednesday, October 1st. Weiss Ratings reiterated a “buy (b)” rating on shares of Allstate in a research report on Wednesday, October 8th. JPMorgan Chase & Co. increased their price objective on Allstate from $254.00 to $260.00 and gave the stock an “overweight” rating in a report on Thursday, November 6th. Barclays restated an “underweight” rating and issued a $198.00 target price (up from $188.00) on shares of Allstate in a research report on Thursday, July 31st. Finally, Roth Capital set a $230.00 price target on Allstate and gave the stock a “buy” rating in a research report on Friday, September 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Allstate has a consensus rating of “Moderate Buy” and an average price target of $237.64.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.